50% off Premium Yearly

NYSE:HCA
This summary was created by AI, based on 2 opinions in the last 12 months.
HCA Healthcare, symbol HCA-N, has garnered favorable reviews from experts, highlighting its effective management and the essential services it provides. The company benefits from a substantial outpatient segment, which one expert personally utilizes, indicating the practicality and necessity of its offerings. Furthermore, HCA Healthcare has demonstrated a consistent commitment to shareholder value through aggressive stock buybacks, successfully reducing its outstanding shares by 44% since 2015. This strategic financial maneuver has contributed to its impressive performance, with the stock reaching new all-time highs recently and showcasing a remarkable increase of 628% over the past decade. Overall, the positive trends both in operations and valuation make HCA Healthcare a prominent player in the healthcare industry.
He's been recommending this post-Covid, because it's been benefitting from the huge bounce back in medical procedures that were delayed. HCA just made a new all-time high. But last Friday it reported a shocking top and bottom line miss. Is down 13% in the past week, but this is an opportunity. HCA missed only slightly, not the end of the world. Hurricanes hit revenues by $200-300 million and 60-90 cents per share, a one-off impact. HCA reaffirmed its full-year forecast, though
(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.
HCA Healthcare is a American stock, trading under the symbol HCA (previously HCA-N on Stockchase) on the New York Stock Exchange (HCA). It is usually referred to as NYSE:HCA or HCA
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on HCA (previously HCA-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for HCA Healthcare.
HCA Healthcare was recommended as a Top Pick by Eric Bushell on 2003-05-28. Read the latest stock experts ratings for HCA Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for HCA Healthcare.
HCA Healthcare is followed by 17 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-18, HCA Healthcare (HCA) stock closed at a price of $376.06.
He likes it a lot. It is very well run and provides needed services with positive trends happening for these services. It has a big outpatient component which he uses himself.